SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-15-000152
Filing Date
2015-02-12
Accepted
2015-02-12 08:12:54
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM 10-Q f10q1214_delmar.htm 10-Q 469016
2 EXHIBIT 31.1 f10q1214ex31i_delmar.htm EX-31.1 10582
3 EXHIBIT 31.2 f10q1214ex31ii_delmar.htm EX-31.2 10259
4 EXHIBIT 32.1 f10q1214ex32i_delmar.htm EX-32.1 3445
5 EXHIBIT 32.2 f10q1214ex32ii_delmar.htm EX-32.2 3190
  Complete submission text file 0001013762-15-000152.txt   3922831

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE dmpi-20141231.xml EX-101.INS 456307
7 XBRL SCHEMA FILE dmpi-20141231.xsd EX-101.SCH 36770
8 XBRL CALCULATION FILE dmpi-20141231_cal.xml EX-101.CAL 26975
9 XBRL DEFINITION FILE dmpi-20141231_def.xml EX-101.DEF 139940
10 XBRL LABEL FILE dmpi-20141231_lab.xml EX-101.LAB 324597
11 XBRL PRESENTATION FILE dmpi-20141231_pre.xml EX-101.PRE 227781
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54801 | Film No.: 15602003
SIC: 2834 Pharmaceutical Preparations